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Mitochondrial DNA impact on joint 
damaged process in a conplastic 
mouse model after being surgically 
induced with osteoarthritis
Morena Scotece1, Ignacio Rego‑Pérez1, Ana Victoria Lechuga‑Vieco2,3,4, 
Alberto Centeno Cortés5, María Concepción Jiménez‑Gómez2, 
Purificación Filgueira‑Fernández1, Carlos Vaamonde‑García1, José Antonio Enríquez2,6 & 
Francisco J. Blanco1,7*
It has been suggested that mitochondrial dysfunction and mtDNA variations may contribute to 
osteoarthritis (OA) pathogenesis. However, the causative link to support this claim is lacking. Here, 
we surgically‑induced OA in conplastic mice in order to evaluate the functional consequences of 
mtDNA haplotypes in their joint degeneration. BL/6NZB strain was developed with C57BL/6JOlaHsd 
nuclear genome and NZB/OlaHsdmtDNA while BL/6C57, which is the original, was developed with 
C57BL/6JOlaHsd nuclear genome and C57/OlaHsdmtDNA for comparison. The surgical DMM OA 
model was induced in both strains. Their knees were processed and examined for histopathological 
changes. Cartilage expression of markers of autophagy, apoptosis, oxidative stress and senescence 
were also analyzed by immunohistochemistry. The joints of BL/6NZB mice that were operated 
presented more cellularity together with a reduced OARSI histopathology score, subchondral bone, 
menisci score and synovitis compared to those of BL/6C57 mice. This was accompanied with higher 
autophagy and a lower apoptosis in the cartilage of BL/6NZB mice that were operated. Therefore, the 
study demonstrates the functional impact of non‑pathological variants of mtDNA on OA process using 
a surgically‑induced OA model. Conplastic (BL/6NZB ) mice develop less severe OA compared to the 
BL/6C57original strain. These findings demonstrate that mitochondria and mtDNA are critical targets 
for potential novel therapeutic approaches to treat osteoarthritis.
Osteoarthritis (OA) is the most common form of arthritis and the leading cause of musculoskeletal disability 
in the elderly. It affects approximately 250 million people worldwide (including at least 40 million in Europe) 
and causes severe disability. Pain is the hallmark symptom of OA, and while it is not a lethal disease, it seriously 
reduces the quality of life and the life expectancy of those suffering from it. The total costs of its treatment induced 
in EU could be as high as 408 to 817 billion €/year1,2. Much of the pathophysiology of OA is yet to be understood, 
but it is a chronic progressive disorder that involves movable joints and is characterized by cellular stress and 
extracellular matrix degradation initiated by micro- and macro-injuries. Altogether, it activates maladaptive 
repair responses, including pro-inflammatory pathways of innate  immunity3.
The role of mitochondria in the pathogenesis of OA has not been studied in detail until relatively recently, 
because cartilage has traditionally been classified as highly glycolytic tissue that derives its energy from anaerobic 
glucose metabolism. However, mitochondrial oxidative phosphorylation (OXPHOS) could account for up to 25% 
of total adenosine triphosphate (ATP) production in articular  cartilage4. There is now a growing body of evidence 
that suggests that mitochondria play a central role in the pathogenesis of  OA5,6. Mitochondrial dysfunction 
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together with mitochondrial DNA (mtDNA) damage contributes to cartilage degradation via several processes 
such as: (1) increased apoptosis; (2) enhanced inflammatory responses; (3) decreased mitochondrial biogenesis; 
(4) increased cartilage catabolism, (5) alterations of mitochondrial dynamics leading to deregulated reactive oxy-
gen species (ROS) production and (6) changes in mitophagy and autophagy  mechanisms7–10. When these changes 
cannot be managed by the repair and anti-oxidant systems, the homeostatic system fails, and mitochondrial 
dysfunction is perpetuated. This leads to progressive cartilage destruction and, eventually, to joint malfunction.
Approximately, between 30 and 65% of the risk of OA is genetically  determined11,12 with evidence accumulated 
from different genome-wide association studies (GWAS)13. Most of these studies have focused on nuclear genetic 
variants. However, over the past decade, evidence has accumulated that there is an association between mtDNA 
haplogroups and the prevalence, progression and incidence of the  disease14–19. This link has been assessed only 
in ex vivo studies and only with the use of in vitro transmitochondrial cybrid  models20. Thus, the causal link 
between mtDNA haplotype variability and OA joint phenotype has not been studied.
Conplastic mice are a powerful tool to investigate the contribution of mtDNA variants to cell physiology 
and  behaviour21. They are developed by backcrossing the nuclear genome from one inbred mouse strain into 
the cytoplasm of another. These mice have a uniform nuclear background, but different mtDNA variants, thus 
enabling the study of the function of the mtDNA variants in an in vivo setting. Several strains of conplastic mice 
have been  developed22. In a recent study, we showed that the extension of healthy again mice was very depend-
ent on the mtDNA  variant23. Since OA is an age associated disease, here we have studied conplastic animals to 
determine whether the substitution of the mtDNA variant would also affect OA development and progression. To 
induce OA, we used the surgical model of destabilization of the medial meniscus (DMM). It is a post-traumatic 
osteoarthritis mouse model that can mimic meniscal injury, which is a predisposing factor for OA development 
in humans. The DMM model allows for the analysis of the structural and biological changes during the disease 
progression and it is currently considered as a gold standard for the study of post-traumatic  OA24.
Thus, we developed the posttraumatic OA model and compared the evolution of both strains by histologi-
cal and immunohistochemistry assays. This study demonstrates that the replacement of mtDNA reduces joint 
degradation.
Results
Development of less severity of cartilage loss and menisci damage by conplastic (BL/6NZB) 
mice after DMM surgery. Osteoarthritis Research Society International (OARSI) histopathology scoring 
system was applied to evaluate OA severity. First, the cartilage degradation process in both BL/6C57 and BL/6NZB 
strains was analyzed separately. As shown in Fig. 1, BL/6C57 mice presented a severe cartilage loss in joint sub-
mitted to the DMM surgery when compared with SHAM joint (Fig. 1A,C, p = 0.0003). However, the induction 
of OA in BL/6NZB was weaker as reported in panels B and D (Fig. 1B,D, p = 0.0534). Interestingly, comparing the 
OARSI score of DMM joint of BL/6C57 with DMM joint of BL/6NZB, it is observed that the development of OA 
in conplastic mice was significantly less severe than in the original strain (Fig. 1E, p = 0.0180). In addition, there 
were no differences between the SHAM joints of BL/6C57 and BL/6NZB mice (Supplementary Figure S1).
Knee meniscus degeneration and damage are linked to the initiation and progression of osteoarthritis. A semi 
quantitative grading system was used to study the menisci alterations based on the analysis of tissue structure, 
cellularity, and matrix staining of Safranin O/Fast Green of both anterior and posterior sections of meniscus. 
There was a significant increase in the score of anterior meniscus in the operated knees of both BL/6C57 (Fig. 1A,F, 
p = 0.0002) and BL/6NZB (Fig. 1B,G, p = 0.0087) strains compared to SHAM knees. There were no significant dif-
ferences in posterior menisci (data not shown). SHAM groups had no differences in both anterior and posterior 
menisci (Supplementary Figure S1).
Moreover, the operated knees of conplastic (BL/6NZB) mice showed less menisci degeneration than the original 
strain; there was statistical significance in the anterior (Fig. 1H, p = 0.0040) but not in the posterior meniscus 
(data not shown).
The exacerbation of subchondral bone changes post‑DMM surgery in BL/6C57 original 
strain. Together with the progressive cartilage degradation, subchondral bone changes are considered as a 
Figure 1.  Attenuation of osteoarthritis development in conplastic (BL/6NZB) mice following destabilization of 
the medial meniscus (DMM). Representative Safranin O/Fast green-stained sections of the knee joints (right 
knee = SHAM; left knee = DMM) of DMM-operated 17-week-old male BL/6C57 (A) and BL/6NZB (B) at 8 weeks 
after surgery. Images show the medial femorotibial compartment of SHAM or DMM-operated knees. Femur 
(F), tibia (T) as well as anterior (A) and posterior (P) location of the menisci are also represented (magnification 
10x). Scale bar, 500 μm. Quantification of cartilage damage in BL/6C57 (C) and BL/6NZB (D) mice at 8 weeks 
following DMM is shown as OARSI score (BL/6C57 = 9; BL/6NZB = 10), a semi quantitative scoring system where 
the minimum value 0 corresponds to the normal cartilage and the maximum value 6 represents a cartilage 
destruction of more that 75% of the articular surface. Comparison of OARSI score between BL/6C57 and BL/6NZB 
mice after DMM surgery (E). Tissue structure (smooth, fibrillation, undulating), cellularity (normal, hyper 
cellularity, hypo cellularity), and matrix staining of Safranin O/Fast Green (normal and disrupted staining) 
were scored and summed together for anterior and posterior menisci. Quantification of anterior meniscus total 
score of BL/6C57 (F) and BL/6NZB (G) after DMM surgery (BL/6C57 = 8; BL/6NZB = 6). Comparison of anterior 
meniscus total score between BL/6C57 and BL/6NZB after DMM surgery (H). All data are shown as mean ± SEM; 
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hallmark of OA. To study the subchondral bone alterations, a score system was used which evaluated the thick-
ening of the bone, number of the trabeculae and the osteophyte formation of the medial tibial plateau (MTP).
As reported in Fig. 2, in both BL/6C57 (Fig. 2A,B, p < 0.0001) and BL/6NZB (Fig. 2C,D, p = 0.0071) strains, there 
was a significant increase of subchondral bone score in operated knee joint (DMM). In the conplastic (BL/6NZB) 
mice, the operated knee joint presented less subchondral bone changes compared to BL/6C57 mice (Fig. 2E, 
p = 0.0353). There were no differences between SHAM groups (Supplementary Figure S1).
Reduction of synovitis post DMM surgery in conplastic (BL/6NZB) mice. Synovial abnormalities 
have been observed at multiple stages of OA. This study measured the synovitis grade by histological analysis of 
synovial tissues after DMM surgery in joints from BL/6NZB and BL/6C57 mice. Three synovial membrane features 
were evaluated: synovial lining cell layer, stroma cell density and inflammatory infiltrate. In Fig. 3, the synovi-
tis total score was significantly reduced in conplastic (BL/6NZB) mice compared to BL/6C57 mice after surgery 
(Fig. 3F). There was a reduction of synovitis score in all the three features analyzed (Fig. 3C,D,E), but there was 
statistical significance only in the inflammatory infiltration (Fig. 3E). In addition, when the SHAM group was 
compared with the DMM group, there was a significant induction of synovitis in both strains (Supplementary 
Figure S2). However, no differences between SHAM groups were observed (Supplementary Figure S2).
Reduced cartilage cellularity and increased apoptosis displayed in BL/6C57 mice submitted to 
DMM model compared to conplastic (BL/6NZB) mice. During the OA process, structural changes of 
cartilage, subchondral bone and menisci are usually accompanied by a reduction of cell density. To evaluate the 
cartilage cellularity, we quantify the number of chondrocytes in H&E sections from BL/6C57 and BL/6NZB after 
DMM surgery. Figure 4 shows that there was a decrease in DMM knees from BL/6C57 mice (Fig. 4A,B, p = 0.0079) 
and BL/6NZB mice (Fig. 4C,D, p = 0.1429) compared with SHAM knees. However, this difference was statisti-
cally significant only in BL/6C57 mice. No differences between SHAM knees were observed (Supplementary Fig-
ure S3). The cartilage cellularity loss during the development of OA was less severe in conplastic (BL/6NZB) mice 
than in the original strain (Fig. 4E, p = 0.0303).
To determine whether the observed reduction in cartilage cellularity was related to cell death by apoptosis, 
the cartilage expression of cleaved caspase-3 was measured. After DMM surgery, cartilage from BL/6NZB mice 
presented significant lower proportion of cleaved caspase-3 (CC3) expression than that of the original strain 
(Fig. 4F,G, p = 0.0290). There was no detectable difference between the SHAM knees of the two strains (Sup-
plementary Figure S4).
Figure 2.  Scoring of subchondral bone changes in tibial plateau from BL/6C57 and BL/6NZB operated mice. 
Representative images of knee joints (right knee = SHAM; left knee = DMM) stained with Safranin O from 
BL/6C57 (A) and BL/6NZB (C) mice (magnification 10×). Scale bar, 500 μm. Subchondral bone thickening, 
number of trabeculae and osteophyte formation graded as normal (grade 0), mild (grade 1), moderate (grade 2) 
or severe (grade 3) were used as parameters to examine the subchondral bone of medial tibial plateau (MTP) in 
mouse knee joints. Quantification of bone changes in BL/6C57 (B) and BL/6NZB (D) mice at 8 weeks (BL/6C57 = 9; 
BL/6NZB = 10) following DMM is shown as subchondral bone score in medial tibial plateau (MTP). Comparison 
of bone changes score between BL/6C57 and BL/6NZB mice after DMM surgery (E). All data are shown as 
mean ± SEM; ***p < 0.001, **p < 0.01, *p < 0.05 by non-parametric Mann–Whitney test.
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Figure 3.  Histological analysis of synovitis in BL/6C57 and BL/6NZB operated mice. Representative images of 
Hematoxylin Eosin (H&E) stained sections from synovium of BL/6C57 mice after DMM surgery (A, n = 9); synovial 
lining cell layer (a, black arrow), stroma cell density (b, blue arrow) and inflammatory infiltrate (c, red arrow). 
Representative images of Hematoxylin Eosin (H&E) stained sections from synovium of BL/6NZB (B, n = 10) mice after 
DMM surgery; synovial lining cell layer (d, black arrow), stroma cell density (e, blue arrow) and inflammatory infiltrate 
(f, red arrow). Quantification of synovial lining cell layer (C), stroma cell density (D) and inflammatory infiltrate (E) in 
BL/6C57 and BL/6NZB operated mice. Quantification of synovitis total score in DMM groups from BL/6C57 and BL/6NZB 
mice (F). Original magnification 20×. Scale bar, 250 μm. All data are shown as mean ± SEM; *p < 0.05 by non-parametric 
Mann–Whitney test. Comparisons with significant differences are indicated; all other comparisons were non-significant.
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Autophagy response following cartilage injury. To study the potential molecular modulations in the 
joints of the mice after being surgically induced with OA, one of the mechanisms that was altered in OA was 
analyzed: the autophagy.
To address the evaluation of autophagy mechanism in both BL/6C57 and BL/6NZB strains, immunohistochem-
istry of LC3 and Beclin-1 proteins was done. From the histological data, there was more expression of protein 
LC3 in sections from operated knee BL/6NZB mice when compared with the original strain, that borderlines 
the statistical significance (Fig. 5A,B, p = 0.0571). Moreover, in comparing the difference in LC3 positive cells 
between SHAM and DMM groups for each strain, it was found that the loss of LC3 from BL/6NZB mice was 
Figure 4.  Changes in cartilage cellularity and cleaved caspase-3 expression in response to surgically OA 
induction. Images from Hematoxylin Eosin (H&E) stained sections of BL/6C57 (A) and BL/6NZB (C) mice knee 
joints (BL/6C57 = 5; BL/6NZB = 6). Original magnification 10×. Scale bar, 500 μm. Chondrocytes magnification 
(20×) is shown on the bottom-left corner of the images. Quantitative analysis of cartilage cell number in the 
medial compartment of BL/6C57 (B) and BL/6NZB (D) mice after DMM surgery. Comparison of cartilage cell 
number between DMM BL/6C57 and DMM BL/6NZB mice (E). Representative images of medial compartment 
of operated (DMM) knee joints from BL/6C57 (left panel F) and BL/6NZB (right panel F) stained with cleaved 
caspase-3 (CC3) antibody. Quantitative analysis of CC3 positive cells of knee joints from BL/6C57(n = 4) and 
BL/6NZB(n = 4) after DMM surgery (G). Original magnification 10×. Scale bar, 500 μm. Black arrow indicate 
positively stained chondrocyte. Graph represents means ± SEM. *p < 0.05 , **p < 0.01 by non-parametric 
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significantly less than the one found in cartilage from BL/6C57 mice (Fig. 5C, p = 0.0464). The expression of pro-
tein Beclin-1 was significantly higher in sections from operated knee BL/6NZB mice than in the original strain 
(Fig. 5D,E, p = 0.0286). SHAM groups presented no differences for both LC3 and Beclin-1 cartilage expression 
(Supplementary Figure S5 and S6).
Discussion
Clinical and in vitro data suggest that specific mtDNA polymorphisms, called mtDNA haplogroups might con-
fer different level of protection/sensitivity to knee  OA11,14–19. Moreover, several studies have confirmed the link 
between OA and mtDNA haplogroups. They have reported the association of mtDNA haplogroups with differ-
ent comorbidities linked to  OA11, such as  obesity25, T2DM (type 2 diabetes mellitus)26 and oxidative  stress27.
To explore in vivo the functional effects of non-pathological mtDNA variants during the development of OA, 
conplastic mice strains (DMM model) were surgically-induced with OA (Supplementary Figure S7). This study 
shows for the first time that the exchange of mtDNA of C57BL/6JOlaHsd mice with mtDNA from NZB/OlaHsd 
mice improves the development of OA features in C57BL/6JOlaHsd strain.
The use of conplastic model has emerged as a potent tool to reveal the nature and extent of mtDNA vari-
ability. Conplastic mice have a uniform nuclear background, but different mtDNA variants, thus enabling the 
study of the function of the mtDNA variants in an in vivo setting. This study used two wild type mtDNA vari-
ants derived from C57BL/6JOlaHsd (also referred as to BL/6C57) and NZB/OlaHsd (BL/6NZB). MtDNA from 
most of the mouse-inbred strain is virtually identical with 1 to 5 single nucleotides of difference, far from the 
natural variation between two human mtDNA (34 SNPs on average and more than 100 between geographically 
distant populations)28. The mtDNA of the NZB/B1NJ strain is enough different from BL/6J mtDNA to resemble 
the sequence difference between human mtDNAs of distant populations (about 90 SNPs)29. The mtDNAs of 
C57BL/6 and NZB/OlaHsd mice differ by 12 missense mutations, 4 transfer RNA (tRNA) mutations, 8 riboso-
mal RNA(rRNA) mutations, and 10 non-coding-region mutations. These correspond with a level of divergence 
comparable to that between human Eurasian and African  mtDNAs23.
The proof-of-concept study demonstrates that mtDNA haplotype profoundly influences mitochondrial pro-
teostasis and reactive oxygen species generation, insulin signaling, and ageing parameters including telomere 
shortening and mitochondrial dysfunction, resulting in profound differences in health longevity between con-
plastic  strains23. The study employed these conplastic animals to determine whether the substitution of the 
mtDNA would also affect the changes in OA development and progression. The study results demonstrate that 
Figure 5.  Immunohistochemistry for LC3 and Beclin-1 were performed on mouse knee joint sections. 
Representative images of medial compartment of operated (DMM) knee joint from BL/6C57 (left panel A) and 
BL/6NZB (right panel A) stained with LC3. Quantitative analysis of LC3 positive cells of knee joints from BL/6C57 
and BL/6NZB after DMM surgery (B). Comparison of the difference in LC3 positive cells between SHAM and 
DMM group (Δ) in joints from BL/6C57 and BL/6NZB mice (C). Representative images of medial compartment 
of operated (DMM) knee joints from BL/6C57 (left panel D) and BL/6NZB (right panel D) stained with Beclin-1 
antibody. Quantitative analysis of Beclin-1 positive cells of knee joints from BL/6C57 and BL/6NZB after DMM 
surgery (E). Original magnification 10×. Scale bar, 500 μm. Black arrow indicate positively stained chondrocyte. 
Chondrocytes magnification (20×) is shown on the bottom-left corner of the images. Graphs represent 
means ± SEM; (BL/6C57 = 4; and BL/6NZB = 4). *p < 0.05, p = 0.0571 by non-parametric Mann–Whitney test.
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the mtDNA haplotype determines joint degradation response. Conplastic (BL/6NZB) mice developed less severe 
OA compared with the original strain, BL/6C57.
Based on the findings of the pathological changes in all of the joint tissues, OA is considered as a disease of 
the joint, resulting in “joint failure”. In this work, the key features of OA in the various joint tissues affected were 
analyzed. The first to be analyzed was the cartilage damage, a key feature in OA pathophysiology; the histologi-
cal scoring method issued by  OARSI30 was used to analyze it in conplastic (BL/6NZB) mice and was compared 
with the original strain, BL/6C57. The OARSI scores revealed that conplastic (BL/6NZB) mice showed less cartilage 
loss than BL/6C57 strain (Fig. 1E). There was a significant increase of OARSI score in DMM group compared to 
SHAM group only in BL/6C57 mice (Fig. 1C).
Menisci are often implicated in OA pathogenesis. Knee meniscus injuries and damage are closely linked to 
the initiation and progression of  OA31–33. We also measured the menisci damage after DMM surgery in both 
strains. A semi quantitative score was calculated to analyze the tissue structure, cellularity, and matrix staining 
of Safranin O/Fast Green of both anterior and posterior sections. Significant results are obtained only in ante-
rior menisci where the conplastic (BL/6NZB) mice developed less menisci alterations compared with the original 
strain after inducing OA experimentally (Fig. 1H). Anterior menisci score was significantly increased in DMM 
groups compared with SHAM in both BL/6NZB and BL/6C57 mice (Fig. 1F,G). In general, in mice, more changes 
in cellular and matrix component characterized the anterior menisci than posterior menisci. In addition, the 
pronounced alterations in the anterior menisci of the DMM model were also likely due to the location of the 
surgically injury in the medial  meniscus34.
Further analysis of the features of OA was done, measuring the subchondral bone changes which together 
with cartilage degradation are widely considered as a hallmark of  OA35. Subchondral bone thickening, number 
of trabeculae and osteophyte  formation30 were used as parameters to examine the subchondral bone of medial 
tibial plateau (MTP) in both strains. The study findings reported a significant increase of subchondral bone score 
of MTP in DMM group compared to SHAM group in both strains (Fig. 2B,D). Conplastic (BL/6NZB) mice showed 
less subchondral bone changes in MTP compared to BL/6C57 mice after DMM surgery (Fig. 2E).
It is known that abnormal accumulation of mtDNA mutations (mutator mice) induces premature aging and 
affects musculoskeletal  tissues36,37. Very recently ,the group of Geurts found that the accumulation of mtDNA 
mutations in the DNA mutator mouse model predispose to elevated subchondral bone turnover and hypertrophy 
in calcified cartilage but not to accelerated development of  osteoarthritis38.
Synovium together with cartilage, bone and menisci plays a critical role in the pathophysiology of  OA39,40. 
This study evaluated the abnormalities of synovium by histological analysis using the Kreen grading  system41. 
Synovium from conplastic (BL/6NZB) mice presented less synovitis compared with BL/6C57 mice after DMM sur-
gery (Fig. 3F). Specifically, there was a significant decrease in the inflammatory infiltration of synovium (Fig. 3E). 
DMM groups from both strains presented more synovitis compared to SHAM groups (Supplementary Figure S2).
Chondrocytes loss is another feature that characterizes OA pathophysiology. So, for completeness, the number 
of total chondrocytes in both strains was also quantified. In knees with experimental OA, there was a reduction 
of cartilage cellularity which reached statistical significance only in BL/6C57 mice (Fig. 4B,D). In comparing 
DMM groups from both strains, it was observed that joint cartilages from BL/6NZB presented more chondrocytes 
compared to the other strain (Fig. 4E).
It is noteworthy that in this animal model consisting of 17 weeks old male mice, there were no differences 
between SHAM groups in all histological studies (Supplementary Figure S1, S2 and S3), confirming that the 
dissimilarities between both strains emerged exclusively for the experimental OA induction. These results agree 
with our study on the role of mtDNA variants in a mouse model of spontaneous OA (manuscript in preparation) 
where there were no alterations of OA between conplastic (BL/6NZB) mice and the original strain during the 
aging process. It was only when there was a joint damage, we observed a different response between the strains. 
This could probably be because the repair mechanism or the catabolic responses are different and they lead to 
a distinct OA response.
Taken together, these histological findings revealed that conplastic (BL/6NZB) mice developed a less severe 
experimental OA, demonstrating that the mtDNA haplotype determines the cartilage, subchondral bone, menisci 
and synovium severity of alterations in OA joint. These observations motivated further study to examine the 
probable mechanisms that give rise to these histological changes in the joint. To assess that, we performed 
immunohistochemistry assay for autophagy, apoptosis, oxidative stress and senescence markers. Two markers of 
oxidative stress (4-HNE and 8-oxo-dG) and two of senescence (β-Galactosidase and MMP-13) were measured. 
However, there were no significant differences between both strains for those factors (data not shown).
It has been demonstrated that compromised autophagy may contribute to the development of  OA42,43, with 
a reduction of both LC3 and Beclin-1 protein expression in OA  chondrocytes42. Accordingly, in this study, it 
was observed a reduced LC3 and Beclin-1 expression in cartilage from DMM groups of both strains reaching 
statistical significance only in BL/6C57 mice for LC3 (Supplementary Figure S5) and in both strains for Beclin-
1(Supplementary Figure S6). The decrease of LC3 and Beclin-1 after DMM surgery was significantly less severe 
in conplastic (BL/6NZB) mice than in BL/6C57 mice (Fig. 5C,E). Furthermore, given that the reduction of these 
key regulators of autophagy is accompanied by an increase in  apoptosis42, we sought to know whether one of 
the key factors of apoptosis, cleaved-caspase-3, was modulated in cartilage from both strains. Effectively, after 
DMM surgery, conplastic (BL/6NZB) mice showed less CC3 cartilage expression than the original strain (Fig. 4G). 
The difference in the autophagy and apoptosis responses from conplastic (BL/6NZB ) mice could be related to a 
greater cartilage cellularity found in those mice after DMM surgery when compared with BL/6C57 strain (Fig. 4E). 
Thus, the reduction of OA severity in conplastic (BL/6NZB ) mice seems to be mediated by a different induction 
of autophagy and specially a lower apoptosis which probably is responsible for the different response to the 
surgically OA induction (Fig. 6).
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A limitation of this study is that the molecular pathways which could be implicated in the differential response 
of knee joint to OA induction in the mice strains analyzed were not investigated. Therefore, this is a descrip-
tive study without previous data on the mice joint before OA induction. This aspect would give a more detailed 
information on the development of the OA pathophysiology in the different mice strains.
The study results demonstrated that substituting the two wild type mtDNA variants affects the joint dete-
rioration, ameliorating the development of OA. In addition, more autophagic response and lower apoptosis 
induction could explain the high cellularity observed in the cartilage and mediated the less severe OA induction 
in conplastic (BL/6NZB) mice (Fig. 6). The demonstration of the causal relationship between mtDNA variants 
and OA highlights that mitochondria should be prominently focused on to develop therapeutic targets and to 
properly stratify patients’ risk to identify the right level of care for distinct patients.
Materials and methods
Animals. Conplastic mice strain were generated in the laboratory of Dr. José Antonio Enríquez23 by back-
crossing females (mitochondrial donors) with males of the parental recipient strain. Parental C57BL/6JOlaHsd 
and NZB/OlaHsd strains were purchased from Harlan Laboratories.
Specifically, conplastic (BL/6NZB) mice strain was developed with the C57BL/6JOlaHsd nuclear genome and 
NZB/OlaHsdmtDNA to compare with the original C57BL/6JOlaHsd strain (BL/6C57).
Mice were bred at the Experimental Surgery Unit of A Coruña under standard conditions (12:12 light: dark 
cycle, + 22 ± 1 °C temperature, 50–60% humidity); and food and water provided ad libitum. After the experiments, 
the animals were sacrificed by carbon monoxide followed by cranial dislocation.
Animal experiments were carried out in accordance with the legislation for the protection of animals (Euro-
pean Directive 2010/ 63) used for scientific purposes, and in compliance with the ARRIVE guidelines. The study 
was approved by the Local Ethical Committee of the Animal Experimentation “Comité de Ètica de Experiment-
ación Animal de la Xerencia de Xestión Integrada A Coruña (CEEA-XXIAC)” and by the “Consellería do Medio 
Rural” of Xunta de Galicia (15002/2018/01).
DMM‑induced OA model. The surgical OA model was induced in 17  weeks old BL/6C57 (n = 10) and 
BL/6NZB (n = 10) male mice by the transection of the medial meniscotibial ligament (DMM: The surgical model 
of destabilization of the medial meniscus) of the hind left knee joint.
In brief, the joint capsule was exposed by cutting the skin 4 mm. The medial meniscus was displayed after 
opening the joint capsule and the meniscotibial ligament was transected. To close the joint capsule and skin 
Figure 6.  Schematic representation of surgically OA development in conplastic (BL/6NZB) mice and BL/6C57 
strain. Created with BioRender.com.
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we used a 7-0 sutures. The contralateral knee that was not operated was used as a control (sham). Analgesic 
(Buprenorphine 0.09 mg/kg sc) and antibiotic (Oxacillin, orally) were administered during the surgery and for 
3 days (analgesic) and 7 days (antibiotic) post-surgery. The animals were euthanized 8 weeks later (Supplemen-
tary Figure S7).
Histological analysis. Knee joints from mice of DMM-induced OA model were harvested. Joints were 
fixed overnight in 3.7–4% formaldehyde and then decalcified in Decal (HistoLab) for 6 h at 100 rpm. This was 
followed by paraffin embedding. Serial sections  (4  μm) were cut, deparaffinized in xylene, and washed in a 
graded series of alcohol.
To analyze the cartilage deterioration in the joint from the DMM model, sagittal sections from right (sham) 
and left (operated) hind knee joints of BL/6NZB and BL/6C57 mice were stained with Safranin O-fast green. They 
were examined for histopathological changes using the histological scoring method issued by OARSI. This is 
a semi quantitative scoring system where the minimum value 0 corresponds to the normal cartilage and the 
maximum value 6 represents a cartilage destruction of more than 75% of the articular  surface30.
Subchondral bone thickening, number of trabeculae and osteophyte formation graded as normal (grade 0), 
mild (grade 1), moderate (grade 2) or severe (grade 3) were used as parameters to examine the subchondral bone 
of medial tibial plateau (MTP) in the knee joints of the  mice30.
Meniscal damage was scored following the histological grading system published by Kwok et al.34. The total 
scores for all criteria tissue structure (smooth, fibrillation, undulating), cellularity (normal, hyper cellularity, 
hypocellularity), and matrix staining of Safranin O/Fast Green (normal and disrupted staining) were summed 
together for anterior and posterior menisci.
Grading of synovial membranes was carried out on routine hematoxylin and eosin (H&E)-stained slides. 
Three synovial membrane features were evaluated: synovial lining cell layer, stroma cell density and inflamma-
tory infiltrate; they were graded as normal (0), slight (1) moderate (2) and severe (3)41.
Sections were blinded and scored by two different experienced scientists. Average scores were used in the 
statistical analyses.
Cartilage cellularity. To analyze the cartilage cellularity, knee joint sections were stained with Hematoxylin 
and Eosin. Three pictures of the center of femoral condyle and tibial plateau of the medial compartment that is 
not covered by the menisci were taken under 40× magnification. Then, the total number of chondrocytes was 
counted in each  section44.
Immunohistochemistry. Mouse knee joint sections were deparaffinized, washed, and incubated with 
primary antibody to LC3 (PM036; MBL; 1:1000), Beclin-1 (ab 62557; Abcam; 1:200) or cleaved caspase-3 
(CC3) (#9664; Cell Signaling; 1:100), 1 h at room temperature. This was followed by the Dako REAL EnVision 
Detection System, Peroxidase/DAB + (K-5007, Dako). Finally, the slides were mounted with DePEX mounting 
medium (Leica Biosystem).
In both right and left mouse knee joints, three pictures of the center of medial femoral condyle and medial 
tibial plateau that is not covered by the menisci were taken using a microscope (LEICA ICC50W). The total 
number of chondrocytes and the number of positive cells for the corresponding antibody were counted in each 
section. The values are expressed as % of positive cells vs total number of  chondrocytes44.
Statistical analysis. The results are given as mean ± standard error of the mean (SEM); statistical analysis 
was performed using the non-parametric Mann–Whitney test. P values less than 0.05 were considered signifi-
cant. Data were analyzed using the Prism computerized package (Graph Pad Prism Software v 6.0, San Diego, 
CA, USA).
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